• share
• favorite_border

Two leading non-profits combine efforts to accelerate cancer immunotherapy clinical trials for patients globally

• share
• favorite_border

Comprehensive immuno-oncology landscape analysis conducted by nonprofit Cancer Research Institute quantifies global development of immunotherapy and identifies opportunities to advance the field to improve patient care

• share
• favorite_border

Fight Colorectal Cancer (Fight CRC) and the Cancer Research Institute (CRI) are proud to announce “A Blueprint to Advance Colorectal Cancer Immunotherapies”

• share
• favorite_border

The Cancer Research Institute will give awards for scientific achievements in immunology and tumor immunology and immunotherapy to three accomplished research scientists at its 31st Annual Awards Dinner on November 14, 2017, in New York City.

• share
• favorite_border

Cancer Research Institute will recognize Genentech and Bruce Ratner for their contributions to medical research, patient care, or public education in the fields of cancer immunology and immunotherapy.

• share
• favorite_border

A collaborative campaign brings together the leading funder of immunotherapy research internationally with North America’s largest nonprofit dedicated to supporting Israeli cancer research

• share
• favorite_border

$400k grant to Johns Hopkins University School of Medicine investigator Cynthia Sears will carry out research aimed at improving effectiveness of immunotherapy in patients with colorectal cancer.

• share
• favorite_border

$1 million CRI Technology Impact Award will support UPENN investigator's development of microchip-based research models that mimic human cancer and immune cell interactions

• share
• favorite_border

CRI's 2017 Immunotherapy Patient Summit Series will travel to five U.S. cities to provide free educational programming designed for cancer patients and caregivers who are seeking to learn more about cancer immunotherapy and clinical trials.

• share
• favorite_border

Day-long endurance event starting at the U.S. Military Academy at West Point, NY, focused on cancer immunotherapy research

• share
• favorite_border

Cancer Immunotherapy Month in June to feature educational and awareness programming for patients, caregivers, and the public

• share
• favorite_border

data from four early-phase immunotherapy combination trials will be presented at the American Society for Clinical Oncology (ASCO) Annual meeting in Chicago on June 5, 2017.

• share
• favorite_border

Nonprofit cancer immunotherapy research organization hires pharmaceutical executive to lead its clinical trials program

• share
• favorite_border

Over the past few years, checkpoint blockade immunotherapies have revolutionized cancer treatment and helped many patients who were previously considered untreatable. Now, discoveries made by two Cancer Research Institute scientists could help make these and other immunotherapies even more transformative for patients.

• share
• favorite_border

Three nonprofits partner to create powerful database that will aim to improve immunotherapy for many types of cancer.

• share
• favorite_border

This Saturday [Dec 3], the 58th Annual Meeting of the American Society of Hematology will begin in San Diego, where the latest advances in research for blood cancers including leukemia, lymphoma, and myeloma will be highlighted during the four days of talks and poster presentations.

• share
• favorite_border

Two nonprofits team up to fund immunotherapy research designed to benefit patients with an ultra-rare form of liver cancer.

• share
• favorite_border

New collaboration between two nonprofits focused on cancer immunotherapy aims to identify new DNA-based targets for personalized cancer treatments

• share
• favorite_border

Nonprofit devoted to cancer immunotherapy will honor the biotech company Amgen for its contributions to cancer immunotherapy treatment and patient education

• share
• favorite_border

Four leading cancer research organizations will host a conference dedicated to the latest in cancer immunotherapy.